Suppr超能文献

隆突性皮肤纤维肉瘤

Dermatofibrosarcoma Protuberans.

作者信息

Acosta Alvaro E, Vélez Catalina Santa

机构信息

Dermatology Department, Instituto Nacional de Cancerología, Universidad Nacional de Colombia, Carrera 19C No. 90-14, Bogotá, Colombia.

Dermatology Oncology Universidad Militar Nueva Granada, Instituto Nacional de Cancerología, Calle 1a No. 9-85, Bogotá, Colombia.

出版信息

Curr Treat Options Oncol. 2017 Aug 10;18(9):56. doi: 10.1007/s11864-017-0498-5.

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a slow growing tumor with a very low metastatic potential but with significant subclinical extension and great capacity for local destruction. Thus, the first surgeon approached with such challenging tumor must attempt to cure the patient with a method that spares healthy tissue and ensures an optimal oncological, functional, and esthetic result. The treatment of DFSP often requires a multidisciplinary approach. Depending on location, dermatologic surgeons, surgical oncologists, head and neck surgeons, neurosurgeons, plastic surgeons, and occasionally medical oncologists may be involved with the management. Mohs micrographic surgery (MMS) is the preferred method when available. In our institution, most of the DFSP cases are often advanced cases; thus, dermatologic surgeons obtain clear margins peripherally and other surgical specialties assist with resection of the fascia and any critical deeper structures. When MMS is not available, wide local excision (at least 2- to 3-cm margins of resection) with exhaustive pathologic assessment of margin status is recommended, and it is best to confirm tumor extirpation prior to any reconstruction. Subclinical extension of the tumor could be related to the size; how long it has been growing or histological markers that are unknown right now. No clinical trials comparing MMS vs WLE are available, and further research should be focused on these subjects as well as the use of imatinib and other targeted therapies for recurrent and metastatic tumors and for neoadjuvant treatment.

摘要

隆突性皮肤纤维肉瘤(DFSP)是一种生长缓慢的肿瘤,转移潜能极低,但具有显著的亚临床扩展和强大的局部破坏能力。因此,首位接诊这种具有挑战性肿瘤的外科医生必须尝试采用一种能保留健康组织并确保获得最佳肿瘤学、功能和美学效果的方法来治愈患者。DFSP的治疗通常需要多学科方法。根据肿瘤位置,皮肤科外科医生、外科肿瘤学家、头颈外科医生、神经外科医生、整形外科医生,偶尔还有医学肿瘤学家可能参与治疗。如有条件,莫氏显微外科手术(MMS)是首选方法。在我们机构,大多数DFSP病例往往是晚期病例;因此,皮肤科外科医生在周边获得清晰切缘,其他外科专科医生协助切除筋膜和任何关键的深部结构。当无法进行MMS时,建议进行广泛局部切除(至少2至3厘米的切除切缘)并对切缘状态进行详尽的病理评估,并且最好在任何重建之前确认肿瘤已被彻底切除。肿瘤的亚临床扩展可能与肿瘤大小、生长时间或目前尚不清楚的组织学标志物有关。目前尚无比较MMS与WLE的临床试验,进一步的研究应聚焦于这些主题以及伊马替尼和其他靶向治疗在复发性和转移性肿瘤以及新辅助治疗中的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验